Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson’s disease male Wistar rat model and effect of melatonin administration

Biogerontology

Volumn 16, Issue 1, 2015, Pages 109-123

  Mattam, Ushodaya ^a   Jagota, Anita ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Clock genes; Melatonin; Parkinson s disease; Rotenone; Serotonin metabolism; Suprachiasmatic nucleus

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; MELATONIN; N ACETYLSEROTONIN; NEUROPROTECTIVE AGENT; ROTENONE; SEROTONIN; TRYPTOPHAN; BMAL1 PROTEIN, RAT; CIRCADIAN RHYTHM SIGNALING PROTEIN; CRY1 PROTEIN, RAT; CRYPTOCHROME; PER1 PROTEIN, RAT; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLOCK; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROTENONE INDUCED PARKINSON DISEASE; SEROTONIN METABOLISM; SUPRACHIASMATIC NUCLEUS; WEIGHT REDUCTION; WISTAR RAT; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; TIME FACTOR;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; CIRCADIAN RHYTHM; CLOCK PROTEINS; CRYPTOCHROMES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MALE; MELATONIN; PARKINSON DISEASE, SECONDARY; PERIOD CIRCADIAN PROTEINS; RATS; RATS, WISTAR; ROTENONE; SEROTONIN; SUPRACHIASMATIC NUCLEUS; TIME FACTORS;

EID: 84922105487     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-014-9541-0     Document Type: Article

References (62)

1. Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16:61–67
2. Aguiar LM, Macedo DS, de Freitas RM, de Albuquerque OA, Vasconcelos SM, de Sousa FC, de Barros Viana GS (2005) Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity. Life Sci 76:2193–2202
3. Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317–324
4. Azmitia EC, Nixon R (2008) Dystrophic serotonergic axons in neurodegerative diseases. Brain Res 1217:185–194
5. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306
6. Beyer K (2007) Mechanistic aspects of Parkinson’s disease: a-synuclein and the Biomembrane. Cell Biochem Biophys 47:285–299
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
8. Cai Y, Liu S, Sothern RB, Xu S, Chan P (2010) Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson’s disease. Eur J Neurol 17:550–554
9. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE (2009) A highly reproducible rotenone model of Parkinson’s disease. Neurobiol Dis 34:279–290
10. Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE (2005) Systemic exposure to paraquat and maneb models early Parkinson’s disease in young adult rats. Neurobiol Dis 20:360–371
11. Cuesta M, Mendoza J, Clesse D, Pévet P, Challet E (2008) Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp Neurol 210:501–513
12. Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909
13. De Blas AL, Cherwinski HM (1983) Detection of antigens on nitrocellulose paper immunoblots with monoclonal antibodies. Anal Biochem 133:214–219
14. Fertl E, Auff E, Doppelbauer A, Waldhauser F (1993) Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of L-dopa. J Neural Transm Park Dis Dement Sect 5:227–234
15. Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson’s disease. Front Neuroendocrinol 35:370–384
16. Grady RK Jr, Caliguri A, Mefford IN (1984) Day/night differences in pineal indoles in the adult pigeon. Comp Biochem Physiol C 78:141–143
17. Gravotta L, Gavrila AM, Hood S, Amir S (2011) Global Depletion of Dopamine Using Intracerebroventricular 6-Hydroxydopamine Injection Disrupts Normal Circadian Wheel-Running Patterns and PERIOD2 Expression in the Rat Forebrain. J Mol Neurosci 45:162–171
18. Hasegawa H, Nakamura K (2010) Tryptophan hydroxylase and serotonin synthesis regulation. In: Müller C, Jacobs B (eds) Handbook of behavioral neurobiology of serotonin. Elsevier B. V., Amsterdam, pp 183–202
19. Hasegawa S, Kanemaru K, Gittos M, Diksic M (2005) The tryptophan hydroxylase activation inhibitor, AGN-2979, decreases regional 5-HT synthesis in the rat brain measured with alpha-[14C]methyl-l-tryptophan: an autoradiographic study. Brain Res Bull 67:248–255
20. Hayashi A, Matsunaga N, Okazaki H, Kakimoto K, Kimura Y, Azuma H, Ikeda E, Shiba T, Yamato M, Yamada K, Koyanagi S, Ohdo S (2013) A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson’s disease. Neuromolecular Med 15:238–251
21. He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W (2003) Role of nitric oxide in rotenone-induced nigro-strital injury. J Neurochem 86:1338–1345
22. Heffner TG, Hartman JA, Seiden LS (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13:453–456
23. Holmes SW, Sugden D (1982) Effects of melatonin on sleep and neurochemistry in the rat. Br J Pharmacol 76:95–101
24. Hood S, Cassidy P, Cossette MP, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S (2010) Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci 30:14046–14058
25. Horikawa K, Yokota S, Fuji K, Akiyama M, Moriya T, Okamura H, Shibata S (2000) Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci 15:5867–5873
26. Iacono RP, Kuniyoshi SM, Ahlman JR, Zimmerman GJ, Maeda G, Pearlstein RD (1997) Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson’s patients with severe postural instability and gait disorders. J Neural Transm 104:451–459
27. Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T (2009) Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience 158:537–544
28. Inden M, Kondo J, Kitamura Y (2003) Differences in rotational asymmetry in rats caused by single intranigral injections of 6-hydroxydopamine, 1-methyl-4-phenylpyridinium ion and rotenone. Biog Amines 17:281–291
29. Jagota A (2006) Suprachiasmatic nucleus: the center for circadian timing system in mammals. Proc Indian Natl Sci Acad B71:275–288
30. Jagota A (2012) Age-induced alterations in biological clock: therapeutic effects of melatonin. In: Thakur MK, Rattan SIS (eds) Brain aging and therapeutic interventions. Springer, Netherlands, London, pp 111–129
31. Jagota A, Kalyani D (2010) Effect of melatonin on age-induced changes in daily serotonin rhythms in suprachiasmatic nucleus of male wistar rat. Biogerontology 11:299–308
32. Jagota A, Reddy MY (2007) The effect of curcumin on ethanol induced changes in suprachiasmatic nucleus (SCN) and pineal. Cell Mol Neurobiol 27:997–1006
33. Jang SW, Liu X, Pradoldej S, Tosini G, Chang Q, Iuvone PM, Ye K (2010) N-acetylserotonin activates TrkB receptor in a circadianrhythm. Proc Natl Acad Sci USA 107:3876–3881
34. Jordan SD, Lamia KA (2013) AMPK at the crossroads of circadian clocks and metabolism. Mol Cell Endocrinol 366:163–169
35. Kamphuis W, Cailotto C, Dijk F, Bergen A, Buijs RM (2005) Circadian expression of clock genes and clock-controlled genes in the rat retina. Biochem Biophys Res Commun 330:18–26
36. Khaldy H, León J, Escames G, Bikjdaouene L, García JJ, Acuña-Castroviejo D (2002) Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75:201–208
37. Kondratov RV, Vykhovanets O, Kondratova AA, Antoch MP (2009) Antioxidant N-acetyl-l-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging (Albany NY) 1:979–987
38. Kudo T, Loh DH, Truong D, Wu Y, Colwell CS (2011) Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol 232:66–75
39. Kuhn DM, Sykes CE, Geddes TJ, Jaunarajs KL, Bishop C (2011) Tryptophan hydroxylase 2 aggregates through disulphide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson’s disease. J Neurochem 116:426–437
40. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
41. Lucas G, De Deurwaerdere P, Caccia S, Spampinato U (2000) The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used. Neuropharmacology 39:1053–1063
42. Mammen AP, Jagota A (2011) Immunocytochemical evidence for different patterns in daily rhythms of VIP and AVP peptides in the suprachiasmatic nucleus of diurnal Funambulus palmarum. Brain Res 1373:39–47
43. Manikonda PK, Jagota A (2012) Melatonin administration differentially affects age-induced alterations in daily rhythms of lipid peroxidation and antioxidant enzymes in male rat liver. Biogerentology 13:511–524
44. Mattam U, Jagota A (2014) Differential role of melatonin in restoration of age-induced alterations in daily rhythms of expression of various clock genes in suprachiasmatic nucleus of male Wistar rats. Biogerontology 15:257–268
45. Mattson MP, Duan W, Wan R, Guo Z (2004) Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx 1:111–116
46. Maximino C (2012) Serotonin and anxiety in neurochemical, pharmacological, and funtional aspects, Springer, p 111
47. Mefford IN, Barchas JD (1980) Determination of tryptophan and metabolites in rat brain and pineal tissue by reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr 181:187–193
48. Mohawk JA, Green CB, Takahashi JS (2012) Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35:445–462
49. Moranta D, Barceló P, Aparicio S, Garau C, Sarubbo F, Ramis M, Nicolau C, Esteban S (2014) Intake of melatonin increases tryptophan hydroxylase type 1 activity in aged rats: preliminary study. Exp Gerontol 49:1–4
50. Muradian KK, Utko NA, Mozzhukhina TG, Litoshenko AY, Pishel IN, Bezrukov VV, Fraifield VE (2002) Pair-wise linear and 3D nonlinear relationships between the liver antioxidant enzyme activities and the rate of body oxygen consumption in mice. Free Radic Biol Med 33:1736–1739
51. Pazo D, Cardinali DP, Cano P, Reyes Toso CA, Esquifino AI (2002) Age-related changes in 24-hour rhythms of norepinephrine content and serotonin turnover in rat pineal gland: effect of melatonin treatment. Neurosignals 11:81–87
52. Reiter RJ, Tan DX, Galano A (2014) Melatonin: Exceeding Expectations Physiology 5:325–333
53. Sawada M, Nagatsu T, Nagatsu I, Ito K, Lizuka R, Kondo T, Narabayashi H (1985) Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients. J Neural Transm 62:107–115
54. Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11:151–167
55. Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson’s disease. Brain Res Mol Brain Res 134:57–66
56. Sparks DL, Slevin JT (1985) Determination of tyrosine, tryptophan and their metabolic derivatives by liquid chromatography-electrochemical detection: application to post mortem samples from patients with Parkinson’s and Alzheimer’s disease. Life Sci 36:449–457
57. Tang JP, Melethil S (1995) Effect of aging on the kinetics of blood-brain barrier uptake of tryptophan in rats. Pharm Res 7:1085–1091
58. Tosini G, Ye K, Iuvone PM (2012) N-Acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain. Neuroscientist 6:645–653
59. Weber M, Lauterburg T, Tobler I, Burgunder JM (2004) Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci Lett 358:17–20
60. Welsh DK, Takahashi JS, Kay SA (2010) Suprachiasmatic nucleus: cell autonomy and network properties. Annu Rev Physiol 72:551–577
61. Yuan H, Zheng JC, Liu P, Zhang SF, Xu JY, Bai LM (2007) Pathogenesis of Parkinson’s disease: oxidative stress, environmental impact factors and inflammatory processes. Neurosci Bull 23:125–130
62. Yujnovsky I, Hirayama J, Doi M, Borrelli E, Sassone-Corsi P (2006) Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK: BMAL1. Proc Natl Acad Sci USA 103:6386–6391